*Short-Term Pain, Long-Term Gain: Nevada Pillow Factory* Welspun's $13M Nevada capex targets high-margin pillow manufacturing, operationalizing June 2026. Strategic move reduces import dependency, captures "Made in USA" premium positioning in US market. Key Numbers: Revenue contribution FY2027+: $8–15M annually. EBITDA impact FY2026 (Jun–Mar): ~50–100 bps margin compression from ramp-up costs. FY2027 onwards: $2–3M+ EBITDA contribution at estimated 20–25% margins. Gross margin initially pressured; rebounds as capacity utilization normalizes. Key Risk: Production ramp-up execution delays could extend FY2026 losses. Demand absorption uncertainty—US pillow market saturation or pricing power erosion reduces upside ceiling. Fixed-cost deleverage during underutilization phases. Strategic Call: *Verdict: Recommend green-light with moderate confidence.* Long-term margin expansion and revenue diversification outweigh near-term transition friction. Monitor Q4 FY2026 capacity utilization closely; capacity underutilization beyond 60% signals demand headwinds requiring corrective action.

*Short-Term Pain, Long-Term Gain: Nevada Pillow Factory* Welspun's $13M Nevada capex targets high-margin pillow manufacturing, operationalizing June 2026. Strategic move reduces import dependency, captures "Made in USA" premium positioning in US market. Key Numbers: Revenue contribution FY2027+: $8–15M annually. EBITDA impact FY2026 (Jun–Mar): ~50–100 bps margin compression from ramp-up costs. FY2027 onwards: $2–3M+ EBITDA contribution at estimated 20–25% margins. Gross margin initially pressured; rebounds as capacity utilization normalizes. Key Risk: Production ramp-up execution delays could extend FY2026 losses. Demand absorption uncertainty—US pillow market saturation or pricing power erosion reduces upside ceiling. Fixed-cost deleverage during underutilization phases. Strategic Call: *Verdict: Recommend green-light with moderate confidence.* Long-term margin expansion and revenue diversification outweigh near-term transition friction. Monitor Q4 FY2026 capacity utilization closely; capacity underutilization beyond 60% signals demand headwinds requiring corrective action.

*Short-Term Pain, Long-Term Gain: Nevada Pillow Factory* Welspun's $13M Nevada capex targets high-margin pillow manufacturing, operationalizing June 2026. Strategic move reduces import dependency, captures "Made in USA" premium positioning in US market. Key Numbers: Revenue contribution FY2027+: $8–15M annually. EBITDA impact FY2026 (Jun–Mar): ~50–100 bps margin compression from ramp-up costs. FY2027 onwards: $2–3M+ EBITDA contribution at estimated 20–25% margins. Gross margin initially pressured; rebounds as capacity utilization normalizes. Key Risk: Production ramp-up execution delays could extend FY2026 losses. Demand absorption uncertainty—US pillow market saturation or pricing power erosion reduces upside ceiling. Fixed-cost deleverage during underutilization phases. Strategic Call: *Verdict: Recommend green-light with moderate confidence.* Long-term margin expansion and revenue diversification outweigh near-term transition friction. Monitor Q4 FY2026 capacity utilization closely; capacity underutilization beyond 60% signals demand headwinds requiring corrective action.

*Short-Term Pain, Long-Term Gain: Nevada Pillow Factory* Welspun's $13M Nevada capex targets high-margin pillow manufacturing, operationalizing June 2026. Strategic move reduces import dependency, captures "Made in USA" premium positioning in US market. Key Numbers: Revenue contribution FY2027+: $8–15M annually. EBITDA impact FY2026 (Jun–Mar): ~50–100 bps margin compression from ramp-up costs. FY2027 onwards: $2–3M+ EBITDA contribution at estimated 20–25% margins. Gross margin initially pressured; rebounds as capacity utilization normalizes. Key Risk: Production ramp-up execution delays could extend FY2026 losses. Demand absorption uncertainty—US pillow market saturation or pricing power erosion reduces upside ceiling. Fixed-cost deleverage during underutilization phases. Strategic Call: *Verdict: Recommend green-light with moderate confidence.* Long-term margin expansion and revenue diversification outweigh near-term transition friction. Monitor Q4 FY2026 capacity utilization closely; capacity underutilization beyond 60% signals demand headwinds requiring corrective action.